Gerresheimer AG (GXI) Receives €73.14 Consensus Target Price from Brokerages

Shares of Gerresheimer AG (ETR:GXI) have received a consensus recommendation of “Hold” from the eleven ratings firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is €73.14 ($86.05).

Several research firms have recently issued reports on GXI. HSBC Holdings plc set a €65.00 ($76.47) price objective on shares of Gerresheimer AG and gave the company a “neutral” rating in a report on Tuesday. Berenberg Bank set a €75.00 ($88.24) price objective on shares of Gerresheimer AG and gave the company a “buy” rating in a report on Wednesday, October 11th. Independent Research GmbH set a €68.00 ($80.00) price objective on shares of Gerresheimer AG and gave the company a “neutral” rating in a report on Wednesday, October 11th. Goldman Sachs Group, Inc. (The) set a €69.50 ($81.76) price objective on shares of Gerresheimer AG and gave the company a “neutral” rating in a report on Thursday, October 12th. Finally, J P Morgan Chase & Co set a €99.40 ($116.94) price objective on shares of Gerresheimer AG and gave the company a “buy” rating in a report on Wednesday, October 11th.

ILLEGAL ACTIVITY NOTICE: “Gerresheimer AG (GXI) Receives €73.14 Consensus Target Price from Brokerages” was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another domain, it was stolen and reposted in violation of US & international trademark & copyright laws. The correct version of this piece of content can be viewed at https://ledgergazette.com/2017/10/18/gerresheimer-ag-gxi-receives-73-14-consensus-target-price-from-brokerages.html.

Shares of Gerresheimer AG (GXI) traded up 1.535% during midday trading on Friday, reaching €67.606. The company’s stock had a trading volume of 35 shares. The company has a market capitalization of €2.12 billion and a P/E ratio of 18.727. The stock has a 50 day moving average of €64.76 and a 200-day moving average of €70.20. Gerresheimer AG has a 1-year low of €59.97 and a 1-year high of €79.47.

Gerresheimer AG Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two division

Several research firms have recently issued reports on GXI. HSBC Holdings plc set a €65.00 ($76.47) price objective on shares of Gerresheimer AG and gave the company a “neutral” rating in a report on Tuesday. Berenberg Bank set a €75.00 ($88.24) price objective on shares of Gerresheimer AG and gave the company a “buy” rating in a report on Wednesday, October 11th. Independent Research GmbH set a €68.00 ($80.00) price objective on shares of Gerresheimer AG and gave the company a “neutral” rating in a report on Wednesday, October 11th. Goldman Sachs Group, Inc. (The) set a €69.50 ($81.76) price objective on shares of Gerresheimer AG and gave the company a “neutral” rating in a report on Thursday, October 12th. Finally, J P Morgan Chase & Co set a €99.40 ($116.94) price objective on shares of Gerresheimer AG and gave the company a “buy” rating in a report on Wednesday, October 11th.

ILLEGAL ACTIVITY NOTICE: “Gerresheimer AG (GXI) Receives €73.14 Consensus Target Price from Brokerages” was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another domain, it was stolen and reposted in violation of US & international trademark & copyright laws. The correct version of this piece of content can be viewed at https://ledgergazette.com/2017/10/18/gerresheimer-ag-gxi-receives-73-14-consensus-target-price-from-brokerages.html.

Shares of Gerresheimer AG (GXI) traded up 1.535% during midday trading on Friday, reaching €67.606. The company’s stock had a trading volume of 35 shares. The company has a market capitalization of €2.12 billion and a P/E ratio of 18.727. The stock has a 50 day moving average of €64.76 and a 200-day moving average of €70.20. Gerresheimer AG has a 1-year low of €59.97 and a 1-year high of €79.47.

Gerresheimer AG Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply